Showing results (121-130 of 296) with videos related to
Sort By:
Pageof 30
Journal of the American Heart Association|February 21, 2016
Post-Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve ImplantationKonstantinos C Koskinas, Stefan Stortecky, Anna Franzone, et al.International Journal of Cardiology|June 2, 2017
Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and designDaniel Tobler, Judith Bouchardy, Engel Reto, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 3, 2021
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE TrialJuan F Iglesias, Dik Heg, Marco Roffi, et al.International Journal of Cardiology|December 21, 2019
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortBaris Gencer, David Carballo, David Nanchen, et al.Journal of the American Heart Association|February 8, 2025
Microcirculatory Resistance After Primary Percutaneous Coronary Intervention Predicts Residual Myocardial Damage and Scar FormationAlessandro Candreva, Alexander Gotschy, Julia Stehli, et al.European Heart Journal|September 1, 2016
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trialKyohei Yamaji, Lorenz Räber, Thomas Zanchin, et al.Circulation. Cardiovascular Interventions|September 17, 2019
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized TrialJuan F Iglesias, Dik Heg, Marco Roffi, et al.The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 7, 2016
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trialAnna Franzone, Masanori Taniwaki, Fabio Rigamonti, et al.International Journal of Cardiology|May 25, 2017
Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohortsAnna Franzone, Stefan Stortecky, Lorenz Räber, et al.Pageof 30